409 Fibronectin (FN), epidermal growth factor-receptor (EGF-R) and heparin-binding epidermal growth factor-like (HB-EGF) urinary expressions and topical toxicity of adjuvant intravesical therapy for non muscle invasive bladder cancer (NMI-BC)
| Autor: | F. Torretta, Vincenzo Serretta, Vincenza Alonge, Gesolfo C. Scalici, S. Caruso, Fiorentino E, Antonio Russo, G. Carità |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Oncology
medicine.medical_specialty Bladder cancer biology business.industry Urology medicine.medical_treatment Urinary system medicine.disease Fibronectin Internal medicine Toxicity medicine biology.protein Cancer research Epidermal growth factor receptor Heparin-binding epidermal growth factor Non muscle invasive business Adjuvant |
| Zdroj: | European Urology Supplements. 13:e409 |
| ISSN: | 1569-9056 |
| DOI: | 10.1016/s1569-9056(14)60404-8 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect